Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

In the present study, MDR-TB, defined as resistance to at least isoniazid and rifampicin was responsible for 14% of the overall number of TB cases and 69% of the drug-resistant

The current study aimed to estimate the incidence of MDR-TB in the city of Santos, describe the profile of TB drug resistance in risk groups and examine the adherence to

The objective of this study was to develop a molecular platform to make a rapid diagnosis of multidrug-resistant (MDR) and extensively drug-resistant TB based on single

A study conducted in South Africa showed that the treatment of one patient with XDR-TB costs US$ 26,392, which is four times higher than the treatment of one patient with MDR-TB

Objective: To determine the incidence of active tuberculosis (TB) among individuals cohabiting with patients infected with susceptible and multidrug-resistant tuberculosis

To gain insight into the epidemiology of childhood drug resistant tuberculosis (DR-TB) in China that has the second largest burden of TB and the largest number of multidrug resis-

Currently available evidence about the role of beda- quiline in MDR-TB has low quality, but the available re- sults of phase II clinical trials suggest that this drug might

Methods: We performed a retrospective case-control study of patients with MDR (cases), XDR (cases) and drug-susceptible (controls) TB in a high-HIV-prevalence setting in South Africa